Bavarian Nordic ramps up monkeypox vaccine production
CEO Paul Chaplin reports that Bavarian is making more doses of its vaccine against monkeypox due to the recent outbreak.
by christian bundgaard, translated by daniel pedersen
Bavarian Nordic can currently boast that it is the only firm in the world to have an approved vaccine against infectious disease monkeypox. The current outbreak has turned the spotlight onto the Danish biotech company, which can no longer keep up with demand for its vaccine.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Bavarian's market value up USD 1bn over three days
For subscribers
